Development and optimization of boswellic acid-loaded proniosomal gel

References

• Abdel TM, Werz O, Schubert-Zsilavecz M. (2011). Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 50:349–69
   PubMed Web of Science ®Google Scholar
• Alam MI, Baboota S, Kohli K, et al. (2010). Pharmacodynamic evaluation of proniosomal transdermal therapeutic gel containing celecoxib. Scienceasia 36:305–11
   Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, et al. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Ammon HP. (2006). Boswellic acids in chronic inflammatory diseases. Planta Med 72:1100–16
   PubMed Web of Science ®Google Scholar
• Ammon HP, Safayhi H, Mack T, et al. (1993). Mechanism of antiinflammatory actions of curcumine and boswellic acids. of and acids. J Ethnopharmacol 38:113–19
   PubMed Web of Science ®Google Scholar
• Ammon HPT, Mack T, Singh GB, et al. (1991). Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 57:203–7
   PubMed Web of Science ®Google Scholar
• Barthe L, Woodley J, Houin G. (1999). Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol 13:154–68
   PubMed Web of Science ®Google Scholar
• Bezerra MA, Santelli RE, Oliveira EP, et al. (2008). Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 76:965–77
   PubMed Web of Science ®Google Scholar
• Culioli G, Mathe C, Archier P, et al. (2003). A lupine triterpene from frankincense (Boswellia sp., Burseraceae). Phytochemistry 62:537–41
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Garcia LJ, Hamamura L, Leite MP, et al. (1973). Pharmacological analysis of the acute inflammatory process induced in the rat’s paw by local injection of carrageenin and by heating. Br J Pharmacol 48:88–96
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Seifert F, Buvari P, et al. (2001). Therapy of active Crohn disease with Boswellia serrata extract H-15. Z Gastroenrol 39:11–17
   PubMed Web of Science ®Google Scholar
• Gupta A, Prajapati SK, Balamurugan M, et al. (2007). Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6:687–93
   Web of Science ®Google Scholar
• Gupta I, Parihar A, Malhotra P, et al. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67:391–5
   PubMed Web of Science ®Google Scholar
• Gupta OP, Sharma N, Chand D. (1994). Application of papaya latex-induced rat paw inflammation: model for evaluation of slowly acting antiarthritic drugs. J Pharmacol Toxicol Methods 31:95–8
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. (1999). Proniosomes: a novel drug carrier preparation. Int J Pharm 185:23–35
   PubMed Web of Science ®Google Scholar
• Huang MT, Badmaev V, Ding Y, et al. (2000). Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors 13:225–30
   PubMed Web of Science ®Google Scholar
• Ibrahim MMA, Sammour OA, Hammad MA, et al. (2008). In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PharmSciTech Sci 9:782–90
   PubMed Web of Science ®Google Scholar
• Kimmatkar N, Thawani V, Hingorani L, et al. (2003). Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Phytomedicine 10:3–7
   PubMed Web of Science ®Google Scholar
• Kochi T, Takeharu N, Takehiro S, et al. (2006). Anti-inflammatory effect of propolis through inhibition of nitric oxide production on carrageenininduced mouse paw edema. Biol Pharm Bull 29:96–9
   PubMed Web of Science ®Google Scholar
• Korchowiec B, Paluch M, Corvis Y, et al. (2006). A Langmuir film approach to elucidating interactions in lipid membranes: 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine/cholesterol/metal cation systems. Chem Phys Lipids 144:127–36
   PubMed Web of Science ®Google Scholar
• Korsmeyer R, Robert G, Eric D, et al. (1983). Peppas mechanism of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
   Web of Science ®Google Scholar
• Lalit SK, Panwar SP, Darwhekar G, et al. (2011). Formulation and evaluation of fluconazole amphiphilogel. Der Pharmacia Lettre 3:125–31
   Google Scholar
• Liu JJ, Nilsson A, Oredsson S, et al. (2002). Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 10:501–5
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Pandey RS, Parihar A, Malhotra P, et al. (2005). Extract of gum resin of Boswellia serrata L. inhibits lipopolysaccaride induced nitric oxide production in rat macrophages along with hypolipidemic property. Ind J Exp Biol 43:509–16
   PubMedGoogle Scholar
• Safayhi H, Sailer ER, Ammon HP. (1995). Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol 47:1212–16
   PubMed Web of Science ®Google Scholar
• Sharma ML, Bani S, Singh GB. (1989). Antiarthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol 11:647–52
   PubMed Web of Science ®Google Scholar
• Sharma S, Thawani V, Hingorani L, et al. (2004). Pharmacokinetic study of 11-keto-β-boswellic acid. Phytomedicine 11:250–60
   Web of Science ®Google Scholar
• Siemoneit U, Koeberle A, Rossi A, et al. (2011). Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol 162:147–62
   PubMed Web of Science ®Google Scholar
• Siemoneit U, Pergola C, Jazzar B, et al. (2009). On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance. Eur J Pharmacol 606:246–54
   PubMed Web of Science ®Google Scholar
• Singh GB, Singh S, Bani S. (1996). Anti-inflammatory actions of boswellic acids. Phytomedicine 3:81–5
   PubMed Web of Science ®Google Scholar
• Skarke C, Kuczka K, Tausch L, et al. (2012). Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures. J Clin Pharmacol 52:1592–600
   PubMed Web of Science ®Google Scholar
• Tausch L, Henkel A, Siemoneit U, et al. (2009). Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. J Immunol 183:3433–42
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. (1998). Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• Vane JR. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232–7
   Web of Science ®Google Scholar
• Villar A, Gosooc MA, Alcaraz MJ, et al. (1987). Some aspects of the inhibitory activity of hypolaetin-8-glucoside in acute inflammation. J Pharm Pharmacol 39:502–7
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GW. (1962). Carrageenan induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc Soc Biol Med 11:502–7
   Google Scholar